RNA SBC to Revenue

Atrium Therapeutics Inc · SBC to Revenue

RNA logo

RNA SBC to Revenue

Current (TTM)15.12%
RNA SBC/Revenue (41.25% → 15.12%)
High-resolution chart · PNG

RNA sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
41.245%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.